 (Gut 1995; 37: 639-642) 
expressed in g/cm2 as mean (SD) was significantly lower at the lumbar spine (1.076 (0.186)) than in the control group (1.155 (0.143), p<0001). This was also the case at the femoral neck (0.887 (0.142) versus 0.965 (0.127), p<0.001). When biopsy, and skeletal x ray. Some 63% of these patients had a significant disturbance of bone metabolism, the most common of which was osteomalacia with or without concomitant osteoporosis, the latter condition being rarely present alone. In a study of 22 treated adult coeliacs, Molteni et al4 utilised single photon absorptiometry to measure bone mineral density (BMD) at the distal radius. These patients' BMD values did not differ from those of age matched controls. In 29 untreated adult patients, however, BMD was significantly lower than in age matched controls but did not correlate with the severity of clinical abnormalities. In an intervention study, Caraceni et al 5 noted that, in 20 untreated coeliac adults, BMD at the distal radius was significantly lower than in age matched controls and that biochemical parameters indicated accelerated bone turnover in the coeliac group. They further observed that 12 months after the institution of a gluten free diet no significant change in BMD had occurred: a result interpreted by these authors as indicating arrest of further bone loss. Equally, no restitution of previously lost bone mass was observed. The basic pathology underlying mineral metabolic derangements in coeliac disease has been well reviewed by Cooke and There were no differences between coeliac and control groups in respect of hysterectomy, exposure to hormone replacement therapy, corticosteroids, exercise, or tobacco or alcohol consumption (Table I ). Age at diagnosis of coeliac disease and institution of a gluten free diet ranged from 0 to 41 years with a median of 8 years. Fifty eight patients reported they had always adhered to a gluten free diet, 17 patients usually adhered, and six patients never adhered. Eighty one matching controls were selected from the normal databases described above. BMD was expressed using the standard area density notation of g/cm2 presented below as means (SD).
Overall, the coeliac patients (n=81) showed a significantly lower mean (SD) spinal BMD (1.076 (0.186)) than the control group (1.155 (0.143); p<0.001). Similarly, BMD at the femoral neck in the coeliac group was 0.887 (0-142) whereas that of the control group was 0-965 (0.127); p<0001. When the two groups were stratified according to their menopausal status, the postmenopausal coeliac patients (Table II) .
Using multiple regression analysis, neither the time since diagnosis of coeliac disease nor reported adherence to gluten free diet was found to exert any significant influence upon BMD. However, BMI was positively correlated with spinal but not femoral neck BMD. Menopausal age correlated significantly with both spinal and femoral neck BMD (Table III) .
Discussion
This study confirms that coeliac disease adversely affects bone mineral density, and that the relationship holds when female coeliac patients are compared with strictly selected controls matched for sex, height and weight, menopausal status and, where applicable, menopausal age. It can be argued that the premenopausal controls should be age matched too. Published reports are divided about the impact of age as a single factor on BMD in the healthy premenopausal patient, however, ' 3 14 and for practical purposes it is generally agreed that peak bone density, achieved in the early third decade is essentially the value with which women later approach the climacteric.
The exact mechanism of the development of osteopenia and osteoporosis in the coeliac patient is incompletely understood.'9 There is no direct correlation between bone derangements and steatorrhoea,15 although the institution of a gluten free diet has been reported to Present lack of understanding of the exact mechanisms involved, makes it difficult to explain our observation that coeliac disease in the premenopausal patient seems to affect the femoral neck BMD alone. This could reflect a differential impact of the calcium/vitamin D malabsorption of coeliac disease on the mainly cortical bone of the femoral neck compared with its effect on the mainly trabecular bone of the lumbar vertebrae. The latter, in the presence of adequate endogenous oestrogen, may be able to maintain BMD in the face of malabsorption of mineral. After the menopause, the loss of endogenous oestrogen removes the spinal protection and both sites then exhibit substantial decrements on BMD when compared with matched non-coeliac controls. On the other hand, this apparent difference could be artefactual, due to the different populations used for selecting the premenopausal and postmenopausal control groups. We would caution that the use of postal recruitment of a registered coeliac population may incur bias. For example, knowledge that BMD was to be measured may have encouraged attendance by a sample partially selected by a positive family history of osteoporosis or a previous history of fractures.
What advice should be offered to patients with coeliac disease to protect them against osteoporosis? Although our multiple regression analysis did not show a significant affect of dietary adherence upon BMD, the numbers of non-adherers was small and the true influence of a gluten free diet upon BMD will require to be assessed in a larger, and ideally, prospective study. But consideration should be given to performing bone mineral densitometry either at the time of diagnosis or at the time of menopause, in order to establish basal values of mineral density at the key areas of spine and hip. The premenopausal patient may then be followed up with two repeat densitometry examinations at yearly intervals in order to establish that BMD is stable. Such patients may then be discharged from densitometric follow up until menopause when a further examination will determine if her BMD requires intervention with HRT or an alternative bone-sparing regime. All postmenopausal patients with coeliac disease should undergo BMD measurement at hip and spine and should be considered for treatment with specific bone-sparing regimens, should a diagnosis of osteoporosis be established.
It should, however, be emphasised that the natural history of bone mineral density in the coeliac patient will remain obscure until prospective studies utilising precise measuring techniques such as DEXA become available.
For the moment coeliac disease should be added to the list of medical conditions whose presence constitutes an indication for bone densitometry.
adult female patients. 
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